Here at the BIO International Convention, we've heard calls from advocates, industry, and the government to further incorporate patient feedback and perspectives into both the regulatory process, in which medicines are reviewed, and the medicine development process. An integrated approach has the potential to benefit everyone. For scientists and developers, further insight into the lives of patients can guide research and help finetune new treatments. For regulators, hearing firsthand patient experiences helps them assess whether the benefits of a potential medicine outweigh the risks for those suffering from disease. Most importantly, for patients, sharing their stories and perspectives can lead to more effective treatments.